DSIP is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use
Oral administration is not viablegastric acid and hepatic first-pass metabolism degrade peptide bonds within minutes, rendering the compounds inactive before reaching systemic circulation
It keeps peptide levels steady without cramming injections too close together
A., Sherr, A., Shirin, S., Solodkina, G., Tapia, E
The Endocrine Society has not issued formal guidelines on GHK-Cu use, and the American Academy of Dermatology has not included it in clinical practice recommendations
Hormone balance , energy optimization , and stress management all contribute to the environment in which regenerative peptides operate